Latest Regulatory Approvals News

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Meteoric Resources is poised for a critical environmental milestone as the Preliminary Environmental Licence for its Caldeira Rare Earth Project is set for approval at the upcoming COPAM meeting. This step could unlock the path to construction and keep the project timeline intact.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

National Storage REIT has entered a definitive agreement to be acquired by a Brookfield and GIC-led consortium for $2.86 per security, valuing the company at $4 billion. The Board unanimously recommends the scheme, pending shareholder and regulatory approvals.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a globally significant palladium-nickel-copper mine in Western Australia, boasting robust returns and a rapid payback period.

Critical Resources Limited has partnered with Canada's Pathway Group to accelerate permitting, funding, and stakeholder engagement for its Mavis Lake Lithium Project, aiming to cement its role in North America's lithium supply chain.

Chimeric Therapeutics has won FDA Orphan Drug Designation for its CHM CDH17 CAR-T therapy targeting gastric cancer, advancing its clinical development with regulatory incentives and potential market exclusivity.

Prominence Energy has secured the last regulatory approval needed to complete its acquisition of the Gawler Hydrogen Project, setting the stage for exploration of natural hydrogen in South Australia.

Discovery Alaska Limited has secured an option to acquire a 100% interest in the Boulder Creek Gold-Silver Project in Idaho, positioning the company for growth amid record precious metal prices.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

BetMakers Technology Group has signed a definitive agreement to acquire Las Vegas Dissemination Company, gaining direct access to major Nevada casino operators and projecting $4.5 million revenue in the first year.

Forrestania Resources has launched a conditional all-scrip takeover offer for Kula Gold, valuing the company at approximately $42.7 million. The Kula board unanimously recommends acceptance, highlighting strategic regional consolidation and operational synergies.